Breast cancer is the most common cancer in women in the western world.
F-FES).
The diffuse large B cell lymphoma (DLBCL) is one of the most common NHL, however, non-Hodgkin lymphoma constitutes only 4% of all primary cancers in women. The typical staging of disease is done using 18-fluorodeoksyglukose ( 
Case report
A 73-year-old female with no significant medical history, two months before PET/CT examination found a tumour in left axillary. At first, she underwent lymphatic node ultrasonography, which revealed large left axilla tumour and the next step tumour fine-needle aspiration (FNA) showed carcinomatose neoplasmatica.
She was referred to breast ultrasonography and mammography, which showed bilateral tumours (right breast 13 ¥ 12 mm, left breast 18 ¥ 13 mm) with BIRADS 5 so the patient underwent a core-needle biopsy. The results showed carcinoma invasivum NST G1 (Ki67 1%), ER (3+) 100% and HER-2 negative in both breasts. Repeated biopsy of the left axillary lymph node did not answer the question what the origin of this tumour was.
Due to inconclusive examination, the patient was referred to PET/CT with (Figure 1. B, C, D) . The examination also showed enlarged cervical nodes without the radiotracer uptake.
To summarise, the examination revealed that lymph node package in left axilla and enlarged cervical nodes were not estrogen positive metastasis from breast cancer.
Therefore, a core-needle biopsy of the left axilla lymph node was done with result of DLBCL Ki67 90%.
For DLBCL staging PET/CT with 18 F-FDG was performed (60' after injection of 3 MBq/kg). Due to the fast progress of the illness in the left axilla, the patient could not raise arms above the head so the examination was done with arms along the body.
The study showed very weak uptake of radiopharmaceuticals in both breast tumours with SUVmax 2.1 (Figure 2. E, F) . The pathological uptakes were present in the left axilla tumour and enlarged cervical nodes, with SUVmax up to 23.4 (Figure 2. F, G, H ). There were no other pathological uptakes. F-FES performed along with FNA or core-needle biopsy allows to establish the right diagnosis and the stage of both diseases.
